Company & Sponsor Intelligence
Feng Gao
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting3
Completed0
Countries1
Therapeutic footprint
stroke
Indexed studies
NCT07390032The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion
stroke · ChinaNA
stroke · ChinaNA
NCT07618052Efficacy and Safety of Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Intracranial Atherosclerotic Large Vessel Occlusion (ANGEL-REBOOT 2)
stroke · ChinaNA
stroke · ChinaNA
NCT07557485Randomized Clinical Trial of Endovascular Treatment for Progressive Stroke With Vertebrobasilar Artery Occlusion
stroke · ChinaNA
stroke · ChinaNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →